Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurosarcoidosis.

Aljoeson Walker1, William Tyor

  • 1*Neurology Service, Ralph H. Johnson VA Medical Center, 109 Bee Street, Charleston, SC 29401, USA. Tyorwr@musc.edu

Current Treatment Options in Neurology
|October 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol for neuroimaging using 7 T MRI in the investigation of baricitinib for reduction of HIV in the CNS: a randomized placebo-controlled trial.

BMC medical imaging·2026
Same author

Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective study.

Journal of neurology·2025
Same author

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA.

Neurology and therapy·2025
Same author

Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis.

Neurology and therapy·2025
Same author

Predictors of visual outcome in optic neuropathy of sarcoidosis.

Journal of neuroimmunology·2025
Same author

Real-world Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates (P4-6.005).

Neurology·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Neurosarcoidosis diagnosis requires careful evaluation. Peripheral symptoms indicate a better prognosis than central nervous system involvement, though both may require advanced therapies.

Area of Science:

  • Neurology
  • Immunology
  • Systemic Inflammatory Disorders

Background:

  • Neurosarcoidosis is a rare multisystem inflammatory disease.
  • Diagnosis relies on thorough clinical assessment.
  • Peripheral neurosarcoidosis generally has a better prognosis than central nervous system (CNS) involvement.

Purpose of the Study:

  • To summarize the clinical presentation and management of neurosarcoidosis.
  • To highlight prognostic factors and therapeutic strategies.

Main Methods:

  • Review of clinical findings in neurosarcoidosis patients.
  • Analysis of treatment responses to glucocorticoids and alternative immunosuppressants.

Main Results:

  • Peripheral symptoms like paresthesias and stocking glove deficits correlate with better outcomes.

Related Experiment Videos

  • Central nervous system involvement, mass lesions, or hydrocephalus may indicate a poorer prognosis and treatment resistance.
  • Glucocorticoids are the primary treatment, with rapid response often observed.
  • Alternative therapies include methotrexate, cyclophosphamide, azathioprine, cyclosporine, chlorambucil, chloroquine, and hydroxychloroquine for refractory cases or steroid-sparing.

    • Conclusions:

    • Neurosarcoidosis management requires individualized treatment strategies.
    • Prognosis varies significantly based on the extent of nervous system involvement.
    • Effective therapies include glucocorticoids and a range of alternative immunosuppressive agents.